Thrombomodulin resistance as a novel prothrombotic pathway in COVID-19
Abstract Hypercoagulability and endothelial dysfunction are strongly involved in the worsening of the clinical condition in COVID-19 patients. In severe cases, the inflammatory process triggers the release of angiopoietin 2, which could decrease circulating thrombomodulin (TM), a major regulatory me...
Saved in:
| Main Authors: | Ana Marco-Rico, Adrián Montaño, Francisco López-Jaime, Ihosvany Fernández-Bello, Pascual Marco-Vera |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-08-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-025-15679-1 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Persisting thrombomodulin resistance at 3 months after liver transplantation in children with cirrhosis
by: Marie-Astrid van Dievoet, et al.
Published: (2025-02-01) -
Thrombomodulin is a stronger indicator of combined oral contraceptives-induced activated protein C pathway resistance in the thrombin generation test than activated protein C
by: Marisa Ninivaggi, et al.
Published: (2024-11-01) -
Evaluation of thrombomodulin (THBD) plasma levels in sickle cell disease and correlation with disease severity
by: Yasmeen M.M. Selim, et al.
Published: (2025-06-01) -
Analysis of soluble thrombomodulin contents in blood serum of patients with non-valvular atrial fibrillation: gender dependence
by: O. N. Ogurkova, et al.
Published: (2025-01-01) -
Association of thrombomodulin with the severity of chronic kidney disease: a cross-sectional study
by: Ming Guo, et al.
Published: (2025-05-01)